Ga-68 dOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: A single-centre retrospective study

Clinical Nuclear Medicine

Volumn 35, Issue 5, 2010, Pages 321-328

  Versari, Annibale ^a   Camellini, Lorenzo ^a   Carlinfante, Gabriele ^a   Frasoldati, Andrea ^a   Nicoli, Franco ^a   Grassi, Elisa ^a   Gallo, Carmine ^a   Giunta, Francesca P ^a   Fraternali, Alessandro ^a   Salvo, Diana ^a   Asti, Mattia ^a   Azzolini, Francesco ^a   Iori, Veronica ^a   Sassatelli, Romano ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

And sensibility; Biopsy; Endosonography; Fine needle; Neuroendocrine tumors; Positron emission tomography; Sensitivity; Tomography; X ray computed

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAAZOCYCLODODECANO N,N',N'',N''' TETRAACETIC ACID DEXTRO PHENYLALALAINE1 TYROSINE3 OCTREOTIDE GA 68; IOMEPROL; RADIOPHARMACEUTICAL AGENT; TAP WATER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG SYNTHESIS; DUODENUM TUMOR; ENDOSCOPIC ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ENHANCEMENT; MALE; MEDICAL RECORD REVIEW; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DUODENAL NEOPLASMS; ENDOSONOGRAPHY; FEMALE; GALLIUM RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; OCTREOTIDE; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77951259729     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181d6677c     Document Type: Article

References (29)

1. Fritscher-Ravens A. Endoscopic ultrasound and neuroendocrine tumours of the pancreas. JOP. 2004;5:273-281. (Pubitemid 41573880)
2. Gibril F, Reynolds JC, Doppman JL, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med. 1996;125:26-34. (Pubitemid 126505336)
3. Ramage JK, Davies AH, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut. 2005;54(suppl 4):IV1-IV16. (Pubitemid 40695259)
4. Rösch T, Lightdale CJ, Botet JF, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 1992;326:1721-1726.
5. Palazzo L, Roseau G, Chaussade S, et al. Pancreatic endocrine tumors: contribution of ultrasound endoscopy in the diagnosis of localization. Ann Chir. 1993;47:419-424.
6. Voss M, Hammel P, Molas G, et al. Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut. 2000;46:244-249. (Pubitemid 30305852)
7. Ginès A, Vazquez-Sequeiros E, Soria MT, et al. Usefulness of EUS-guided fine needle aspiration (EUS-FNA) in the diagnosis of functioning neuroendocrine tumors. Gastrointest Endosc. 2002;56:291-296.
8. Ardengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc. 2004; 60:378-384. (Pubitemid 39164246)
9. Jani N, Khalid A, Kaushik N, et al. EUS-guided FNA diagnosis of pancreatic endocrine tumors: new trends identified. Gastrointest Endosc. 2008;67:44-50. (Pubitemid 350266630)
10. DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med. 2004;141:753-763. (Pubitemid 39524913)
11. Gouya H, Vignaux O, Augui J, et al. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. Am J Roentgenol. 2003;181:987-992. (Pubitemid 37151778)
12. Hofmann M, Maecke H, Börner R, et al. Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur J Nucl Med. 2001;28:1751-1757. (Pubitemid 33141238)
13. Kowalski J, Henze M, Schuhmacher J, et al. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol. 2003;5:42-48. (Pubitemid 36596544)
14. Buchmann I, Henze M, Engelbrecht S, et al. Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2007;34:1617-1626. (Pubitemid 47476920)
15. Gabriel M, Decristoforo C, Kendler D, et al. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007;48:508-518. (Pubitemid 47571404)
16. Breeman WA, de Jong M, de Blois E, et al. Radiolabelling DOTA-peptides with 68Ga. Eur J Nucl Med Mol Imaging. 2005;32:478-485.
17. Solcia E, Kloppel G, Sobin LH. Histological typing of neuroendocrine tumours. In: WHO International Histological Classification of Tumours. 2nd ed. Berlin, Germany: Springer; 2000.
18. Rindi G, Kloppel G, Ahlman M, et al. TMN staging of (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395-401. (Pubitemid 44451313)
19. Bundschuh RA, Martínez-Moeller A, Essler M, et al. Postacquisition detection of tumor motion in the lung and upper abdomen using list-mode PET data: a feasibility study. J Nucl Med. 2007;48:677-679. (Pubitemid 47604976)
20. Kumbasar B, Kamel IR, Tekes A, et al. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS. Abdom Imaging. 2004;29:696-702. (Pubitemid 39331706)
21. Alsohaibani F, Bigam D, Kneteman N, et al. The impact of preoperative endoscopic ultrasound on the surgical management of pancreatic neuroendocrine tumors. Can J Gastroenterol. 2008;22:817-820.
22. Horwhat JD, Paulson EK, McGrath K, et al. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions. Gastrointest Endosc. 2006;63:966-975. (Pubitemid 43776157)
23. Micames C, Jowell PS, White R, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUSguided FNA vs. percutaneous FNA. Gastrointest Endosc. 2003;58:690-695. (Pubitemid 37370481)
24. Rocca R, De Angelis C, Daperno M, et al. Endoscopic ultrasound-fine needle aspiration (EUS-FNA) for pancreatic lesions: effectiveness in clinical practice. Dig Liver Dis. 2007;39:768-774. (Pubitemid 47046635)
25. Gill KR, Scimeca D, Stauffer J, et al. Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence? JOP. 2009;10:515-517.
26. Piani C, Franchi GM, Cappelletti C, et al. Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading. Endocr Relat Cancer. 2008;15:175-181. (Pubitemid 351449737)
27. Kwekkeboom DJ, de Herder WW, Kam BL, et al. Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3] octreotate: toxicity, efficacy, and survival. J Clin Oncol. 2008;26:2124-2130.
28. Thomas-Marques L, Murat A, Delemer B, et al. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol. 2006;101:266-273. (Pubitemid 43381666)
29. Sanduleanu S, De Bruïne A, Stridsberg M, et al. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acidsuppressive therapy. Eur J Clin Invest. 2001;31:741-743. (Pubitemid 34203475)